Platt FM - Search Results

1

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.

Jeyakumar M, Norflus F, Tifft CJ, Cortina-Borja M, Butters TD, Proia RL, Perry VH, Dwek RA, Platt FM. Jeyakumar M, et al. Among authors: platt fm. Blood. 2001 Jan 1;97(1):327-9. doi: 10.1182/blood.v97.1.327. Blood. 2001. PMID: 11133779 Free article.

2

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Fischer PB, Collin M, Karlsson GB, James W, Butters TD, Davis SJ, Gordon S, Dwek RA, Platt FM. Fischer PB, et al. Among authors: platt fm. J Virol. 1995 Sep;69(9):5791-7. doi: 10.1128/JVI.69.9.5791-5797.1995. J Virol. 1995. PMID: 7543588 Free PMC article.

3

N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.

Platt FM, Neises GR, Karlsson GB, Dwek RA, Butters TD. Platt FM, et al. J Biol Chem. 1994 Oct 28;269(43):27108-14. J Biol Chem. 1994. PMID: 7929454 Free article.

4

N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.

Platt FM, Neises GR, Dwek RA, Butters TD. Platt FM, et al. J Biol Chem. 1994 Mar 18;269(11):8362-5. J Biol Chem. 1994. PMID: 8132559 Free article.

5

Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.

Block TM, Lu X, Platt FM, Foster GR, Gerlich WH, Blumberg BS, Dwek RA. Block TM, et al. Among authors: platt fm. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2235-9. doi: 10.1073/pnas.91.6.2235. Proc Natl Acad Sci U S A. 1994. PMID: 8134380 Free PMC article.

6

Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120.

Karlsson GB, Butters TD, Dwek RA, Platt FM. Karlsson GB, et al. Among authors: platt fm. J Biol Chem. 1993 Jan 5;268(1):570-6. J Biol Chem. 1993. PMID: 8416962 Free article.

7

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

Fischer PB, Karlsson GB, Butters TD, Dwek RA, Platt FM. Fischer PB, et al. Among authors: platt fm. J Virol. 1996 Oct;70(10):7143-52. doi: 10.1128/JVI.70.10.7143-7152.1996. J Virol. 1996. PMID: 8794361 Free PMC article.

8

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.

Fischer PB, Karlsson GB, Dwek RA, Platt FM. Fischer PB, et al. Among authors: platt fm. J Virol. 1996 Oct;70(10):7153-60. doi: 10.1128/JVI.70.10.7153-7160.1996. J Virol. 1996. PMID: 8794362 Free PMC article.

9

Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin.

Platt FM, Neises GR, Reinkensmeier G, Townsend MJ, Perry VH, Proia RL, Winchester B, Dwek RA, Butters TD. Platt FM, et al. Science. 1997 Apr 18;276(5311):428-31. doi: 10.1126/science.276.5311.428. Science. 1997. PMID: 9103204

10

Inhibition of N-glycan processing in B16 melanoma cells results in inactivation of tyrosinase but does not prevent its transport to the melanosome.

Petrescu SM, Petrescu AJ, Titu HN, Dwek RA, Platt FM. Petrescu SM, et al. Among authors: platt fm. J Biol Chem. 1997 Jun 20;272(25):15796-803. doi: 10.1074/jbc.272.25.15796. J Biol Chem. 1997. PMID: 9188477 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters